In addition, we collected multiple datasets and performed K‐M survival analyses and found that higher GLO1 expression levels were significantly associated with a more unfavorable prognosis in patients with breast cancer (Figure 5M; Figure S6F, Supporting Information). Here, GLO1 is linked to breast cancer.